NaokiKashihara Japan

Wcn26 Post edited Speaker Card

28 March 2026

Time

Session

10:45 a.m.

12 p.m.

Global Kidney Policy Forum: Japan’s CKD Strategy in Action — Lessons From an Aging Society

IfeomaUlasi Chair ifeomaulasi@yahoo.co.ukNigeria

Addressing Kidney Disease in Japan: How Does the National Policy Meet Global Commitments

YosukeYamada Speaker yamada-yousuke.y66@mhlw.go.jpJapan
Transforming Kidney Care Through National Strategy: A Nephrologist Perspective

NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan
Living the Strategy: A Patient’s Perspective on Navigating Kidney Care in Japan

TakeshiShukunobe Speaker takeshi.shukunobe@ppecc.jpJapan
Financing Kidney Health: Sustainable and Innovative National Approaches

YusukeSuzuki Speaker yusuke@juntendo.ac.jpJapan

315

29 March 2026

Time	Session

8:10 a.m. 9:10 a.m.	Industry Symposium 5 HiddoLambers Heerspink Chair H.J.Lambers.Heerspink@umcg.nlNetherlands NaokiKashihara Chair kashinao@med.kawasaki-m.ac.jpJapan Clinical impacts and importance of minimizing drug approval delay (include approval process in US/Europe) NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan HCE (hierarchical composite end points) and eGFR slope, as potential solutions to delays in approval HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Bridging Academia and Regulators in Kidney Drug Development: Insights from Japan MototsuguTanaka Speaker mototsugu.tanaka@gmail.comJapan Panel Discussion HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands MototsuguTanaka Speaker mototsugu.tanaka@gmail.comJapan NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 301 - 302
12:50 p.m. 1:50 p.m.	Industry Symposium 13 KeiFukami Chair fukami@med.kurume-u.ac.jpJapan The Importance of Guideline Directed Therapy Christoph Wanner Speaker wanner_c@ukw.deGermany Long-term Management of Hyperkalemia with Safety NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 315
5 p.m. 6 p.m.	Industry Symposium 30 YOSHITAKAISAKA Chair isaka@kid.med.osaka-u.ac.jpJapan Transformative Insights from the DAPA-CKD Trial: Lessons for the Future of Kidney Care NaokiKashihara Speaker kashinao@med.kawasaki-m.ac.jpJapan 501 - 502